Van Loocke P, Beuselinck B, Meulemans J, Nuyts S, et al. Impact of time-of-day administration of immune checkpoint inhibitors on survival outcomes in patients with recurrent/metastatic head and neck cancer (R/M HNSCC): a retrospective cohort study. Oral Oncol 2025;171:107772.
PMID: 41202429